|
Racotumomab,Nimotuzumab or Docetaxel in the treatment of the advanced non-small cell lung cancer. |
26/05/2014 |
CIM |
|
PrevengHo-Vir Homeoprohylaxis COVID-2019 |
13/05/2020 |
MINSAP_MNT |
|
Predictor of response with CIMAvax EGF© in NSCLC Phase III |
29/01/2016 |
CIM |
|
Pneumococcal conjugate vaccination among Warao children |
2013-06-14 |
SAIB |
|
PLASMA TREATMENT TO ASYMPTOMATIC PATIENT WITH COVID-19 INFECTION |
03/07/2020 |
IHI |
|
Phase II clinical trial for the evaluation of the therapeutic vaccine candidate Terap C. |
2009-02-11 |
CIGB |
|
Phase II / III. Nimotuzumab in patients with triple-negative breast cancer. |
23/05/2014 |
CIM |
|
Phase I/II clinical trial for the evaluation of vaccine candidate CIGB-230 in patients with chronic renal insufficiency. |
2010-09-27 |
CIGB |
|
Pharmacokinetics of the Intralesional administration of rhEGF (doses: 75 µg and 225 µg) in advance Diabetic Foot Ulcers |
2013-02-08 |
CIGB |
|
Nimotuzumab-pancreatic cancer-adults-Phase IV. |
30/04/2017 |
CIM |
|
Nimotuzumab in tumors of head and neck .Phase IV |
2013-02-01 |
CIMAB |
|
NGcGM3/VSSP/Montanide ISA 51 vaccine for breast cancer IIa, IIb and IIIa surgically treated with positive ganglia and disease-free, Phase IIb/III. |
2010-12-17 |
CIM |
|
NGcGM3/VSSP in small cell lung cancer |
07/12/2016 |
CIM |
|
NGcGM3/VSSP in Metastatic melanoma |
07/12/2016 |
CIM |
|
NeuroEPO in stroke |
02/08/2018 |
CIM |
|
NAcGM3/VSSP/Montanide ISA 51 formulation in HIV, phase II. |
2010-12-29 |
CIM |
|
Mindfulness and development of well-being in the couple relationship experience of young adults: A protocol of a randomized controlled trial |
13/11/2019 |
DIRECCION DE IN... |
|
MAGINC Study |
2011-07-12 |
CIGB |
|
IVD in colon cancer |
06/01/2023 |
HHA |
|
Itolizumab (T1h) combined with insulin in patients with Type I Diabetes Mellitus |
23/12/2016 |
CIM |
